70 results on '"Grayson, Peter C."'
Search Results
2. Development of the Takayasu's Arteritis Integrated Disease Activity Index
3. Reply to three letters‐Betrains‐Castaneda‐Hemmig for AR‐22‐0212.R1 and AR‐22‐0213.R1
4. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: ASingle‐CenterProspective Study
5. Association of18 F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis
6. VEXAS Syndrome and Disease Taxonomy in Rheumatology
7. Reply
8. Physician Global Assessment as a Disease Activity Measure for Relapsing Polychondritis
9. Clinicopathologic Associations in a Large International Cohort of Patients With Giant Cell Arteritis
10. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
11. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
12. VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With Vasculitis
13. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
14. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis
15. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
16. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
17. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa
18. Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis
19. Reply
20. Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient‐, Physician‐, Imaging‐, and Laboratory‐Based Assessments
21. Defining Clinical Subgroups in Relapsing Polychondritis: A Prospective Observational Cohort Study
22. Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort
23. Stenosis and Pseudostenosis of the Upper Extremity Arteries in Large‐Vessel Vasculitis
24. Sarcoidosis Concomitant With Takayasu Arteritis, Identified by Advanced Molecular Imaging
25. Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis
26. Use of “Provisional” Designation for Response Criteria
27. 18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
28. Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation
29. Review: Neutrophils as Invigorated Targets in Rheumatic Diseases
30. Clinical Images: Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient
31. Brief Report: Defining the Nasal Transcriptome in Granulomatosis With Polyangiitis (Wegener's)
32. Musculoskeletal Ultrasound Objective Structured Clinical Examination: An Assessment of the Test
33. Illness Perceptions and Fatigue in Systemic Vasculitis
34. Raynaud's Phenomenon
35. Digital Ischemia in Systemic Sclerosis
36. Polyarteritis Nodosa
37. Hyperuricemia and incident hypertension: A systematic review and meta-analysis
38. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.
39. Reply.
40. Association of 18 F-Fluorodeoxyglucose-Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis.
41. 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.
42. 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis.
43. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.
44. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis.
45. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.
46. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
47. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
48. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
49. Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
50. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.